Skip to main content
Premium Trial:

Request an Annual Quote

Invitrogen Obtains Rights to Orchid s SNP-Scoring Technology

NEW YORK, Nov. 28 – Invitrogen has acquired the exclusive rights to develop and market genotyping products utilizing Orchid’s SNP-scoring primer extension technology in a 96-well format, the companies said Wednesday.

Under the terms of the deal, Invitrogen of San Diego will pay Orchid of Princeton, NJ, a royalty on kit sales. 

"The agreement with Orchid is consistent with our strategy of in-licensing high potential technologies,” Lyle Turner, CEO of Invitrogen, said in a statement. “Now we can bring the premier technology for accurate, rapid and flexible SNP genotyping to scientists worldwide."

Invitrogen has also obtained the rights to provide customers with access to the SNP primer design algorithms Orchid provides through its website. 

Orchid said that it would benefit from Invitrogen’s marketing and sales infrastructure.

"With their worldwide sales and marketing coverage, Invitrogen is an acknowledged leader in providing technically advanced reagent kits to thousands of laboratories," Jack Ball, senior vice president and general manager of Orchid's Life Sciences Group, said. 

Orchid's proprietary SNP-IT primer extension technology provides is designed to allow researchers to generate hundreds of SNP genotypes per day.

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.